A New Site and Mechanism of Action for the Widely Used Adenylate Cyclase Inhibitor SQ22,536

Andrew C. Emery(National Institute of Mental Health), Lee E. Eiden(National Institute of Mental Health)

Molecular Pharmacology

October 12, 2012

10.1124/mol.112.081760

Cited by 35

Related Papers

Ligand Bias at Metabotropic Glutamate 1a Receptors: Molecular Determinants That Distinguish β-Arrestin-Mediated from G Protein-Mediated Signaling

|Molecular Pharmacology|2012|46

NCS-Rapgef2, the Protein Product of the Neuronal<i>Rapgef2</i>Gene, Is a Specific Activator of D1 Dopamine Receptor-Dependent ERK Phosphorylation in Mouse Brain

|eNeuro|2017|34

Guanine nucleotide exchange factor Epac2–dependent activation of the GTP-binding protein Rap2A mediates cAMP-dependent growth arrest in neuroendocrine cells

|Journal of Biological Chemistry|2017|26

Cocaine-Dependent Acquisition of Locomotor Sensitization and Conditioned Place Preference Requires D1 Dopaminergic Signaling through a Cyclic AMP, NCS-Rapgef2, ERK, and Egr-1/Zif268 Pathway

|Journal of Neuroscience|2020|26

Cocaine-dependent acquisition of locomotor sensitization and conditioned place preference requires D1 dopaminergic signaling through a cyclic AMP, NCS-Rapgef2, ERK and Egr-1/Zif268 pathway

|bioRxiv (Cold Spring Harbor Laboratory)|2020|0